PARIS, (Sept. 7, 2004) – Sanofi-Aventis said that the subsequent offering period in its French, German and United States offers for Aventis expired simultaneously on September 6 at 5 p.m. (Eastern).
Accordingly, holders of Aventis ordinary shares and ADSs may no longer tender into the offers and may not withdraw Aventis ordinary shares and ADSs that have already been tendered, the company said.
Sanofi-Aventis expects that the French Autorite des marchis financiers (AMF) will publish the definitive final results of the offers on September 16. Sanofi-Aventis intends to issue a press release regarding the definitive final results of the offers promptly after the announcement by the AMF.
In accordance with the requirements of the New York Stock Exchange, Sanofi-Aventis said that as of 5 p.m. (Eastern) on September 6, a total of approximately 752,392 Aventis ADSs (including 241,429 Aventis ADSs subject to the guaranteed delivery period) had been tendered in and not withdrawn from the U.S. offer during the subsequent offering period.
Based on data provided by Aventis, these tenders represent approximately 25 percent of the approximately 2.9 million Aventis ADSs issued and outstanding as of that date.